Evidation Health announced it has closed $45 million in Series D funding and Sam Marwaha has been named chief commercial officer. These are the details.
Hi Marley, the leading communication platform built for insurance, announced it raised $8 million in Series A1 funding. These are the details about the funding.
Fivetran, a leading provider of automated data integration, announced that it raised $100 million in Series C funding. Now the company has a valuation of $1.2 billion.
Upsolver, a company that develops software that eliminates the high engineering overhead of operating cloud data lakes, announced it has raised $13 million in Series A funding.
SQream — a provider of a data analytics acceleration platform that enables enterprises to gain insights from their massive data stores — announced that it has raised $39.4 million.
Artiva Biotherapeutics, an oncology company focused on developing and commercializing allogeneic natural killer (NK) cell therapies, announced that it has launched and closed $78 million.
Landed, a San Francisco-based company that helps essential professionals build financial security near the communities they serve, announced that it raised $10.5 million
Oscar — the first direct-to-consumer health insurance company — announced that it has raised $225 million in funding. These are the details about the funding.
Derivative Path, a leading capital markets financial technology and services company, announced that it raised $35 million in growth equity funding from FTV Capital.
Basketball star and entrepreneur LeBron James and his business partner Maverick Carter announced that they have launched a new media company called SpringHill Co.
Librestream — a leading provider of augmented worker enterprise solutions — announced that it raised $24 million in Series D funding from new and existing investors.
HelloOffice, a technology-powered commercial real estate brokerage making the search for office space seamless and intelligent, announced it raised $20 million.
AsclepiX Therapeutics — a biopharmaceutical company that uses computational biology to identify potent peptide regulators of vascular homeostasis for the treatment of retinal and other important diseases — announced that it raised $35 million.